Curis, Inc. (CRIS) vs Decoy Therapeutics Inc. (DCOY)
A side-by-side comparison of Curis, Inc. and Decoy Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 10:14 AM EDT
DCOY
Decoy Therapeutics Inc.
$1.66HealthcareDelayed quote: Oct 6, 2026, 10:12 AM EDT
Total return — CRIS vs DCOY
growth of $100 · dividends reinvested · last 10yCRIS -100.0% (-58.5%/yr)DCOY -100.0% (-79.2%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
CRIS DCOY
CRIS vs DCOY: by the numbers
- •CRIS is the larger company ($1M vs $883067 market cap).
- •Both run net losses; DCOY's is the smaller (0.00% vs -490.33% net margin).
Metrics side by side
Valuation
| Metric | CRIS | DCOY |
|---|---|---|
| P/S ratio | 0.34 | N/A |
| P/B ratio | 0.31 | 0.20 |
Profitability
| Metric | CRIS | DCOY |
|---|---|---|
| Gross margin | 99.28% | 0.00% |
| Operating margin | -348.43% | 0.00% |
| Net margin | -490.33% | 0.00% |
| ROE | -450.54% | -334.41% |
| ROIC | -567.17% | -343.55% |
Growth (annualized)
| Metric | CRIS | DCOY |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | N/A |
| Total return CAGR (5Y) | -81.06% | -86.39% |
Frequently asked
- How have CRIS and DCOY total returns compared?
- Over the past 10 years, CRIS delivered -59.09% and DCOY delivered -79.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.